期刊文献+

生物学变异质量规范在干化学和常规化学检测系统间比对中的应用

The application of biological variation quality specifications to the comparison betweendry and conventional chemical detection systems
下载PDF
导出
摘要 目的应用生物学变异质量规范评估不同参考区间的干化学和常规化学检测系统间的差异是否具有显著性。方法应用文献报道的参考改变值的公式转化为临床应用可接受的临界差异(CD)公式,再建立CD与个体内生物学变异和分析变异在不同检测系统下的关系,分别计算在95%和99%概率下的最优、期望、最低CD值。对17个常规生化检测项目在不同参考区间的干化学和常规化学检测系统上的相对偏差进行对比分析,以生物学变异质量规范的最优、期望、最低标准判断同一项目在2套检测系统间结果是否具有显著性差异或高度显著性差异。结果95%概率时有7个、99%概率时有13个项目达到最优质量规范,95%概率时有6个、99%概率时有4个项目达到期望质量规范,95%概率时有4个项目达到最低质量规范,在两套检测系统上17个常规生化项目检测结果无显著性差异或高度显著性差异。结论采用生物学变异质量规范模式评估不同参考区间的干化学和常规化学检测系统间的差异是否具有显著性的CD公式法具有简单易、操作性、针对性和实用性较强等特点,可为检验科工作人员提供一种不同检测系统间比对的评估方案。 Objective Biological variation quality specifications were applied to evaluate whether or not the differences between dry and conventional chemical detection systems at different reference intervals were significant.Methods The formula of the reference change value(RCV)reported in the literature was converted into the formula of acceptable critical difference(CD)for clinical application,Then the relationship between CD and individual endobiological variation(CVI)and analysis variation(CVA)under different detection systems was established,Calculate the optimal,expected,and lowest CD values with a 95%and 99%probability,respectively.The relative deviations of 17 conventional biochemical items in dry chemical and conventional chemical detection systems at different reference intervals were compared and analyzed to determine whether the results of the same item had significant or highly significant differences between the two test systems according to the optimal,expected and minimum standards of biological variation quality specifications.Results There was 7 items at the probability of 95%and a 99%chance that 13 items at the probability of 99%,which it met the optimal quality specification,There was 6 items at the probability of 95%and 4 items at the probability of 99%,which it met the desired quality specification,There was 4 items at the probability of 95%,which it met the minimum quality specification.There was no significant difference or highly significant difference in the test results of 17 conventional biochemical items on the two test systems.Conclusion Using the biological variation quality specification model to evaluate whether the difference between dry and conventional chemical testing systems at different reference intervals is significant,the CD formula method has the characteristics of simplicity,operability,pertinence and practicability,which can provide a kind of evaluation scheme for comparing different testing systems for laboratory staff.
作者 徐传华 袁世梅 廖俐雅 余晓辉 罗淋丹 XU Chuanhua;YUAN Shimei;LIAO Liya;YU Xiaohui;LUO Lindan(Department of laboratory medicine Dianjiang people′s Hospital of Chongqing,Dianjiang,Chongqing 408300,China)
出处 《现代医药卫生》 2020年第23期3780-3782,共3页 Journal of Modern Medicine & Health
关键词 化学技术 分析 参考值 对比研究 生物学变异质量规范 临界差异 Chemistry techniques Analytical Reference values Comparative study Quality specification for biological Critical difference
  • 相关文献

参考文献9

二级参考文献59

  • 1陈文祥,申子瑜,杨振华.临床检验分析质量指标的设定[J].中华检验医学杂志,2006,29(4):298-300. 被引量:51
  • 2Fraser CG. General strategies to set quality specifications for reliability performance characteristics. Scand J Clin Lab Invest, 1999,59:487-490.
  • 3Skitek M. Acceptability limits based on biology goals in haematology EQAS. Accred Qual Assur,2005,10 : 112-115.
  • 4Klee GG. Establishment of outcome-related analytic performance goals. Clin Chem ,2010,56:714-722.
  • 5Ric6s C,Alvarez V, Cava F, et al Current databases on biological variation :pros, cons and progress. Scand J Clin Lab Invest, 1999, 59:491-500.
  • 6Ricos C, Lglesias N, Garcta-lario JV, et al Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Bichem,2007,44:343-352.
  • 7Fraser CG. Biological variation: from principles to practice. Washington DC : AACC Press, 2001:2-13.
  • 8Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci, 1989, 27:409-437.
  • 9James Westgard Founder. European Biologic Goals [DB/OL]. Westgard QC, 2012. [2011-11-13]. http ://www. westgard.com/ europe.htm.
  • 10James Westgard Founder. Desirable Specifications for Total Error, Imprecision, and Bias, derived from intra- and inter-individual biologic variation [ DB/OL ]. Westgard QC, 2012. [2011-11-13]. http ://www. westgard. com/biodatabasel. htm.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部